Polymeropoulos Mihael Hristos

CIK 00013555371 companyROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001355537

Recent Transactions

50 trades

Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-08-07$4.15/sh+10,000→ 2,335,731 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-05-21$4.39/sh+481→ 2,325,731 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-05-21$4.40/sh+9,519→ 2,325,250 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-05-16$4.22/sh+20,000→ 2,315,731 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-03-06$5.01/sh+5,000→ 2,295,731 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-03-06$5.02/sh+5,000→ 2,290,731 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-03-05$5.01/sh+5,000→ 2,280,731 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-03-05$5.03/sh+5,000→ 2,285,731 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-03-03$4.71/sh+10,000→ 2,275,731 total
Tax Payment
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-03-01$4.76/sh−95,999→ 2,265,731 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-02-28$4.76/sh+10,000→ 2,361,730 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-02-27$4.76/sh+10,000→ 2,351,730 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-02-26$4.78/sh+5,000→ 2,341,730 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-02-26$4.75/sh+5,000→ 2,336,730 total
Purchase
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-02-25$4.46/sh+10,000→ 2,331,730 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-02-18+450,000→ 2,321,730 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2024-03-05$4.13/sh−24,288→ 1,871,730 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2024-03-04$4.24/sh−30,884→ 1,896,018 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2024-02-16+450,000→ 1,926,902 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2023-03-03$6.25/sh−22,538→ 1,476,902 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2023-03-02$6.23/sh−22,426→ 1,499,440 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2023-02-16+115,000→ 1,521,866 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Stock Option (Right to Buy)
2023-02-16+275,000→ 275,000 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-12-06$3.12/sh+75,365→ 1,455,116 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-12-06$10.61/sh−48,250→ 1,406,866 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Stock Option (Right to Buy)
2022-12-06−75,365→ 0 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-12-05$10.62/sh−47,650→ 1,379,751 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-12-05$3.12/sh+74,635→ 1,427,401 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Stock Option (Right to Buy)
2022-12-05−74,635→ 75,365 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-03-02$11.15/sh−29,588→ 1,352,766 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-03-01$11.19/sh−7,508→ 1,382,354 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Stock Option (Right to Buy)
2022-02-28+275,000→ 275,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-02-28+115,000→ 1,389,862 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-12-01$16.00/sh−46,200→ 1,274,862 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2021-12-01−71,676→ 0 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-12-01$4.88/sh+71,676→ 1,321,062 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-11-30$16.49/sh−50,000→ 1,249,386 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-11-30$4.88/sh+78,324→ 1,299,386 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2021-11-30−78,324→ 71,676 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-03-08$18.00/sh−175,000→ 1,221,062 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-03-02$18.34/sh−15,206→ 1,396,062 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-03-01$18.45/sh−7,479→ 1,411,268 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-02-24+115,000→ 1,418,747 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2021-02-24+275,000→ 275,000 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2020-12-15−46,663→ 0 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-12-15$8.75/sh+46,663→ 1,342,897 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-12-15$13.00/sh−39,150→ 1,303,747 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-12-14$13.19/sh−51,049→ 1,296,234 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-12-14$8.75/sh+61,520→ 1,347,283 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2020-12-14−61,520→ 46,663 total

Companies

Vanda Pharmaceuticals Inc.
Director, Chief Executive Officer
$VNDA

Recent Filings

Address

9605 MEDICAL CENTER DRIVE SUITE 300

ROCKVILLE, MD, 20850

View on SEC.gov